|
시장보고서
U.S. Overactive Bladder Market
|
Abstract
This research service covers the U.S. overactive bladder market from
2005-2015. Included is a disease overview, product analysis, total market
revenue forecasts, product revenue forecasts, patient forecasts and market
share analysis. The market is segmented by product: Detrol, Detrol LA,
Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and
others. Major market challenges, drivers, and restraints and identified and
discussed as well as pipeline by phase.
Table of Contents
1. Executive Summary
U.S. Overactive Bladder Market
2. Market Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Market Engineering Measurements
- Disease Overview
- Treatment Options
- Patient Forecasts
- Industry Challenges
- Market Drivers
- Market Restraints
Product Analysis
- Product Analysis
- Product Comparisons
- Recently Approved Products
Pipeline Analysis
- Phase III
- Phase II
- Phase I
3. Competitive Analysis
Overview
Forecasts and Trends
- Total Market
- Revenue Forecasts by Product
Market Share Analysis
- Company Market Share
- Product Market Share
- Drug Delivery Market Share
4. Appendix
Decision Support Databases
- Population 65 Plus
- Female Population 65 Plus
- Male Population 65 Plus
- Total Life Expectancy at Birth
- Birth Rate
|
